Chemistfrog

Long only, growth, momentum, contrarian
Chemistfrog
Long only, growth, momentum, contrarian
Contributor since: 2010
Company: Chemistfrog on Twitter
1/14/14
Chemistfrog
Interview With Fabrus President Dr. Vaugh Smider $SVON http://seekingalpha.com/a/15nnj
with snti your buying half a share since you only own 50% of each company with each share purchased...how is this is good for topline data
1/15/14
1 divided by 2 is not absolutely .5 depending on synergies. I suspect, presently not enough info is out to determine either way.
12/30/13
Chemistfrog
Imminent Catalysts Should Keep Investor Interest Strong For Venaxis In 2014 $APPY http://seekingalpha.com/a/15695
5/22/13
Chemistfrog
Been buying safer stocks as of late. Work is too busy to babysit volatile pennies except for very small positions.
Wow.. Good luck and be careful sir. Sell some on the way up to secure gains in my opinion.. Best of luck ahead! Vacation here I come! :)
Success to you as well. Your research has been a great tool.
5/22/13
Chemistfrog
Watching metals #silver & #gold closely. Specifically trading $GDXJ, $GDX and $USLV. #oversold?
5/22/13
Chemistfrog
Loving how biotechs have been performing! However, be careful. If market tops, the big runners drop hardest...
5/22/13
Chemistfrog
Strong move again by $ACRX today! $7.26 PPS with $270 million market cap!
5/22/13
Chemistfrog
$BIOD should continue garnering interest up to the P2 data release. Strong move in the last week!
4/28/13
Chemistfrog
$GLD I'm still bullish here! Will sell to reduce at $143 and $149, while holding rest w/trailing stop limits..
LOL! How did NUGT go? Sold my $GLD at 142 when it appeared to be struggling and chart was looking scary... Considering a $JJC entry...
Considering a 50/50 position mix in $GDX and $GDXJ, or adding $GLD back into the mix as well. Any opinions?
4/20/13
Chemistfrog
$SUPN I believe entry down here is wise. Q1 financials could really give the company momo.. Final approval for Trokendi in June/July
You have any opinion on cytk? Keeps coming up on my radar along with supn.
$CYTK chart is in breakout mode. Many catalysts ahead for 13. Watch earnings release for phase IIb update.. I like the company. Good future.
4/20/13
Chemistfrog
$ACRX simply looks "ready" :) Q2 data is imminent...
4/20/13
Chemistfrog
$INO traded down due to poor data from collaborator using their own DNA. Updates on the company using their own DNA could really push it up
4/20/13
Chemistfrog
$APPY sold off a bit last week and recovered Friday. I sold 1/2 into strength and am holding remainder..
4/20/13
Chemistfrog
$CTSO is an exciting small company. Cytosorb is approved in Europe. Any IND filings for US clinicals would be huge..
4/20/13
Chemistfrog
$AAPL is another one of those that I believe has been bashed down to current levels. I believe it wise to start accumulating here & lower..
4/20/13
Chemistfrog
$TROV sold off last week. I accumulated a bit more as I can't believe it is down here. Looking for company updates..
4/20/13
Chemistfrog
$SNRE still illiquid, but I believe it is HIGHLY UNDERVALUED. I have a small position but will add on any + clinical updates.
4/20/13
Chemistfrog
$BIOD looking strong. I will continue to accumulate here, but would LOVE to see $2.50 before run up to September data release.
2/21/13
Chemistfrog
$PAY I cannot see this dropping from these levels. watching to see if immediate inverse head-and-shoulders, bleed down or gradual recovery.
2/5/13
Chemistfrog
$ACRX looks to be consolidating for the next leg up. Before or after 1Q data release? $MTP with many imminent catalysts
9/28/12
Chemistfrog
EXEL should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $EXEL
8/4/12
Chemistfrog
$DCTH trading near its all-time low despite earnings and company update on August 7th and NDA re-filing in August.
8/6/12
Company updates usually keep stocks level until the news is out. you know, making sure there are no surprises. Just buy more if you think.
7/3/12
Chemistfrog
$CHTP, way oversold once again on bad FDA news.... down but not out?!
agreed .. adding to my position at these sub 1.00 levels
5/15/12
Chemistfrog
$CTSO.OB, I'm so surprised to see this trading near their 52-week low! Mark CE approval with solid science. U.S. trials likely next...
5/28/12
What is Mark CE or CE Mark? Celenese is not your field.
1/29/12
Chemistfrog
ALXA, with the FDA panel's huge "book", it's no wonder FDA needs another 3 months!
1/29/12
Chemistfrog
Watching immunotherapy cancer stock plays. Lots of potential there as evident by my last articles.
12/24/11
Chemistfrog
Cormedix CRMD consolidation at this level. Several insider buys in December also. DD this before Monday. CE Mark 1H 2012. Cash thru 2012.
12/16/11
Chemistfrog
CRMD, Cormedix, nice volume & consolidation last couple trading sessions. BIG 2012 AHEAD. CTSO.OB DARPA PR any day.. ANIP rebound to PDUFA?
12/3/11
Chemistfrog
IMUC, ImmunoCellular Therapeutics trading at support. I think it has a great 2012 ahead of it!
12/3/11
Chemistfrog
Loving oversold biotechs that haven't "caught back up" yet: CRMD, CTSO.OB, PPHM, BIOD, DCTH, CLSN, CRIS, LPTN and EXEL.
CC is Tues, I bought in case they have good news about licensing or resuming their program I'll sell on spike. If no news at CC dump it..
12/7/11
nice spike
11/19/11
Chemistfrog
Short term plays mostly for now. I like CTSO.OB for flip or long term, however at these levels.
11/16/11
Chemistfrog
Invested in only short-term positions only as the market and economic situation of the country is very unstable.
11/16/11
Amen, sir...Amen!
11/16/11
Chemistfrog
Currently loving entry positions in CRMD and CTSO.OB. CRMD is way oversold with an exciting 2012 ahead of it. CTSO DARPA funds any day..